Agree. $2 per share would be great at this point. I know $5 plus is thrown around constantly but that would make this stock more than a billion dollar buyout and I can imagine any company paying that much for a stock that can’t even figure out FDA approval and/or manufacturing processes in the 5-7 years that they have been at it.
News 
Market Data 
Discover 
